Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Pancreatic cancer: branched-chain amino acids as putative key metabolic regulators

L. Rossmeislová, J. Gojda, K. Smolková

. 2021 ; 40 (4) : 1115-1139. [pub] 20211228

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

E-resources Online Full text

NLK ProQuest Central from 1997-06-01 to 1 year ago
Medline Complete (EBSCOhost) from 2009-12-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-06-01 to 1 year ago
Public Health Database (ProQuest) from 1997-06-01 to 1 year ago

Branched-chain amino acids (BCAA) are essential amino acids utilized in anabolic and catabolic metabolism. While extensively studied in obesity and diabetes, recent evidence suggests an important role for BCAA metabolism in cancer. Elevated plasma levels of BCAA are associated with an increased risk of developing pancreatic cancer, namely pancreatic ductal adenocarcinoma (PDAC), a tumor with one of the highest 1-year mortality rates. The dreadful prognosis for PDAC patients could be attributable also to the early and frequent development of cancer cachexia, a fatal host metabolic reprogramming leading to muscle and adipose wasting. We propose that BCAA dysmetabolism is a unifying component of several pathological conditions, i.e., obesity, insulin resistance, and PDAC. These conditions are mutually dependent since PDAC ranks among cancers tightly associated with obesity and insulin resistance. It is also well-established that PDAC itself can trigger insulin resistance and new-onset diabetes. However, the exact link between BCAA metabolism, development of PDAC, and tissue wasting is still unclear. Although tissue-specific intracellular and systemic metabolism of BCAA is being intensively studied, unresolved questions related to PDAC and cancer cachexia remain, namely, whether elevated circulating BCAA contribute to PDAC etiology, what is the biological background of BCAA elevation, and what is the role of adipose tissue relative to BCAA metabolism during cancer cachexia. To cover those issues, we provide our view on BCAA metabolism at the intracellular, tissue, and whole-body level, with special emphasis on different metabolic links to BCAA intermediates and the role of insulin in substrate handling.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019612
003      
CZ-PrNML
005      
20220804135826.0
007      
ta
008      
220720s2021 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10555-021-10016-0 $2 doi
035    __
$a (PubMed)34962613
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Rossmeislová, Lenka $u Department of Pathophysiology, Center for Research On Nutrition, Metabolism, and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Franco-Czech Laboratory for Clinical Research On Obesity, Third Faculty of Medicine, Prague, Czech Republic $1 https://orcid.org/0000000276117585 $7 xx0095550 $7 xx0102461
245    10
$a Pancreatic cancer: branched-chain amino acids as putative key metabolic regulators / $c L. Rossmeislová, J. Gojda, K. Smolková
520    9_
$a Branched-chain amino acids (BCAA) are essential amino acids utilized in anabolic and catabolic metabolism. While extensively studied in obesity and diabetes, recent evidence suggests an important role for BCAA metabolism in cancer. Elevated plasma levels of BCAA are associated with an increased risk of developing pancreatic cancer, namely pancreatic ductal adenocarcinoma (PDAC), a tumor with one of the highest 1-year mortality rates. The dreadful prognosis for PDAC patients could be attributable also to the early and frequent development of cancer cachexia, a fatal host metabolic reprogramming leading to muscle and adipose wasting. We propose that BCAA dysmetabolism is a unifying component of several pathological conditions, i.e., obesity, insulin resistance, and PDAC. These conditions are mutually dependent since PDAC ranks among cancers tightly associated with obesity and insulin resistance. It is also well-established that PDAC itself can trigger insulin resistance and new-onset diabetes. However, the exact link between BCAA metabolism, development of PDAC, and tissue wasting is still unclear. Although tissue-specific intracellular and systemic metabolism of BCAA is being intensively studied, unresolved questions related to PDAC and cancer cachexia remain, namely, whether elevated circulating BCAA contribute to PDAC etiology, what is the biological background of BCAA elevation, and what is the role of adipose tissue relative to BCAA metabolism during cancer cachexia. To cover those issues, we provide our view on BCAA metabolism at the intracellular, tissue, and whole-body level, with special emphasis on different metabolic links to BCAA intermediates and the role of insulin in substrate handling.
650    _2
$a větvené aminokyseliny $x metabolismus $7 D000597
650    _2
$a kachexie $x etiologie $7 D002100
650    12
$a duktální karcinom slinivky břišní $x etiologie $x patologie $7 D021441
650    12
$a diabetes mellitus $7 D003920
650    _2
$a lidé $7 D006801
650    12
$a inzulinová rezistence $7 D007333
650    _2
$a obezita $x komplikace $x metabolismus $7 D009765
650    12
$a nádory slinivky břišní $x patologie $7 D010190
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Gojda, Jan $u Franco-Czech Laboratory for Clinical Research On Obesity, Third Faculty of Medicine, Prague, Czech Republic $u Department of Internal Medicine, Královské Vinohrady University Hospital and Third Faculty of Medicine, Prague, Czech Republic $1 https://orcid.org/0000000279955947
700    1_
$a Smolková, Katarína $u Laboratory of Mitochondrial Physiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic. katarina.smolkova@fgu.cas.cz $1 https://orcid.org/0000000247340200 $7 xx0139595
773    0_
$w MED00009430 $t Cancer metastasis reviews $x 1573-7233 $g Roč. 40, č. 4 (2021), s. 1115-1139
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34962613 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135819 $b ABA008
999    __
$a ok $b bmc $g 1822997 $s 1170855
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 40 $c 4 $d 1115-1139 $e 20211228 $i 1573-7233 $m Cancer metastasis reviews $n Cancer Metastasis Rev $x MED00009430
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...